CSF1 and Miyoshi myopathy: Considering that SRC acts downstream the CSF-1 pathway [144,145] and given that increased serum levels of this cytokine associate with higher aggressiveness of different tumor types [50], this study also analyzed the serum levels of CSF-1 in MM patients.